Technical information
Manufacturer
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Presentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
S8x48wFUMXd9Ms6b